(Q40772764)

23 September 2017

Prognostic value of Ki67 in localized prostate carcinoma: a multi-institutional study of >1000 prostatectomies (English)

1 reference

23 September 2017

1 reference

19

L D True

1 reference

23 September 2017

M S Tretiakova

1

1 reference

23 September 2017

W Wei

2

1 reference

23 September 2017

H D Boyer

3

1 reference

23 September 2017

L F Newcomb

4

1 reference

23 September 2017

S Hawley

5

1 reference

23 September 2017

H Auman

6

1 reference

23 September 2017

F Vakar-Lopez

7

1 reference

23 September 2017

J K McKenney

8

1 reference

23 September 2017

L Fazli

9

1 reference

23 September 2017

J Simko

10

1 reference

23 September 2017

D A Troyer

11

1 reference

23 September 2017

A Hurtado-Coll

12

1 reference

23 September 2017

I M Thompson

13

1 reference

23 September 2017

P R Carroll

14

1 reference

23 September 2017

W J Ellis

15

1 reference

23 September 2017

M E Gleave

16

1 reference

23 September 2017

P S Nelson

17

1 reference

23 September 2017

D W Lin

18

1 reference

23 September 2017

Z Feng

20

1 reference

23 September 2017

J D Brooks

21

1 reference

23 September 2017

3 May 2016

1 reference

Prostate Cancer and Prostatic Diseases

23 September 2017

1 reference

23 September 2017

19

1 reference

23 September 2017

3

1 reference

23 September 2017

264-270

1 reference

Tissue biomarkers for prognosis of prostate cancer: a systematic review and meta-analysis

23 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5536893

Prognostic prostate tissue biomarkers of potential clinical use.

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5536893

Ki-67 is an independent predictor of metastasis and cause-specific mortality for prostate cancer patients treated on Radiation Therapy Oncology Group (RTOG) 94-08.

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5536893

Prognostic value of Ki-67 for prostate cancer death in a conservatively managed cohort.

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5536893

A model for the design and construction of a resource for the validation of prognostic prostate cancer biomarkers: the Canary Prostate Cancer Tissue Microarray

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5536893

The role of treatment modality on the utility of predictive tissue biomarkers in clinical prostate cancer: a systematic review

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5536893

Objective quantification of the Ki67 proliferative index in neuroendocrine tumors of the gastroenteropancreatic system: a comparison of digital image analysis with manual methods

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5536893

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5536893

Diagnostic and prognostic molecular biomarkers for prostate cancer

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5536893

Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5536893

Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5536893

Canary Prostate Active Surveillance Study: design of a multi-institutional active surveillance cohort and biorepository

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5536893

Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5536893

Ki67 staining index and neuroendocrine differentiation aggravate adverse prognostic parameters in prostate cancer and are characterized by negligible inter-observer variability

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5536893

Minimum information specification for in situ hybridization and immunohistochemistry experiments (MISFISHIE)

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5536893

Topoisomerase IIalpha in Wilms' tumour: gene alterations and immunoexpression.

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5536893

An intra- and interobserver reproducibility analysis of the Ki-67 proliferation marker assessment on core biopsies of breast cancer patients and its potential clinical implications.

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5536893

Proliferation of immature tumor vessels is a novel marker of clinical progression in prostate cancer

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5536893

Reporting recommendations for tumor marker prognostic studies (REMARK).

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5536893

Overdiagnosis Due to Prostate-Specific Antigen Screening: Lessons From U.S. Prostate Cancer Incidence Trends

19 August 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2016.12

Perineural invasion and MIB-1 positivity in addition to Gleason score are significant preoperative predictors of progression after radical retropubic prostatectomy for prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2016.12

Immunohistochemical analysis of p16, p53, and Ki-67 expression in uterine smooth muscle tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2016.12

Prognostic significance of proliferation activity and neuroendocrine differentiation to predict treatment failure after radical prostatectomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2016.12

Immunohistochemical expression of Ki-67 antigen, cox-2 and Bax/Bcl-2 in prostate cancer; prognostic value in biopsies and radical prostatectomy specimens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2016.12

Expression of potential molecular markers in prostate cancer: correlation with clinicopathological outcomes in patients undergoing radical prostatectomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2016.12

Increased Akt and phosphorylated Akt expression are associated with malignant biological features of prostate cancer in Japanese men

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2016.12

Dichotomizing continuous predictors in multiple regression: a bad idea

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2016.12

Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS Cohort

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2016.12

Maximum Ki-67 staining in prostate cancer provides independent prognostic information after radical prostatectomy

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27136741

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/PCAN.2016.12

1 reference

Dimensions Publication ID

23 September 2017

1002786048

0 references

Fatcat ID

release_rgxkbg4ji5a2ffn7azbht5fc3a

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rgxkbg4ji5a2ffn7azbht5fc3a

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

23 September 2017

PubMed publication ID

27136741

1 reference